Cellular detection of sst2A receptors in human gastrointestinal tissue

Gut
M GuggerJean Claude Reubi

Abstract

Many neuroendocrine gastrointestinal tumours express receptors for the regulatory peptide somatostatin. Among the five existing somatostatin receptor (sst) subtypes, sst2A is the most frequently expressed in these tumours. However, little information is available about the cellular location of sst2A in corresponding non-neoplastic epithelial tissues. We searched for sst2A immunoreactive cells in non-neoplastic gastrointestinal tissues, and evaluated their number and immunohistochemical characteristics with neuroendocrine markers. The gastric antrum showed numerous sst2A cells, situated in the epithelium, corresponding to gastrin containing neuroendocrine cells, while the gastric corpus was largely devoid of sst2A cells, including enterochromaffin-like cells. The remaining foregut, namely the duodenum and proximal jejunum, also contained a large number of sst2A cells, all being neuroendocrine cells and many of them characterised as gastrin cells. Sst2A cells were also detected in the midgut, in low numbers in the epithelium of the distal jejunum and ileum, but not in the appendix vermiformis, the caecum, or the hindgut, despite the large number of neuroendocrine cells present in this area. In addition, sst2A cells were found in ...Continue Reading

References

Sep 28, 1979·Science·L I LarssonT W Schwartz
Jan 1, 1987·The American Journal of Surgical Pathology·Y DayalH J Wolfe
Oct 1, 1980·The Journal of Clinical Investigation·K DharmsathaphornJ W Dobbins
Jan 1, 1983·Virchows Archiv. A, Pathological Anatomy and Histopathology·L Auböck, H Höfler
Jan 25, 1996·The New England Journal of Medicine·S W LambertsL J Hofland
Jul 1, 1996·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·O Nilsson
Jul 17, 1998·The American Journal of Pathology·J C ReubiA Schonbrunn
Dec 29, 1998·Scandinavian Journal of Gastroenterology. Supplement·Z Tulassay
Mar 18, 1999·The New England Journal of Medicine·M H Kulke, R J Mayer
Oct 31, 2001·Naunyn-Schmiedeberg's Archives of Pharmacology·M Rettenbacher, J C Reubi
Oct 2, 2002·European Journal of Pharmacology·Midori KomasakaToshihiko Murayama
Apr 15, 2003·The Journal of Physiology·Laura PiquerasVicente Martínez
Aug 16, 2003·Endocrine Reviews·Jean Claude Reubi

❮ Previous
Next ❯

Citations

Nov 5, 2013·Trends in Pharmacological Sciences·Jean Claude Reubi, Agnes Schonbrunn
Nov 28, 2006·Nature Reviews. Cancer·Susan A WatsonArjun Takhar
Oct 12, 2010·Nuclear Medicine Communications·Manu ShastryJamshed B Bomanji
Aug 30, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Edith Mensah-OsmanJuanita L Merchant
Dec 1, 2011·Scandinavian Journal of Gastroenterology·Herbert F Helander, Lars Fändriks
Mar 15, 2016·Best Practice & Research. Clinical Endocrinology & Metabolism·Meike Körner
Jun 27, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J Van Op den BoschJ-P Timmermans
Sep 5, 2007·Alimentary Pharmacology & Therapeutics·G ScaglioneI Sorrentini
Nov 26, 2010·Biochemical and Biophysical Research Communications·Eiichi OgawaNobuya Inagaki
Aug 28, 2014·Journal of Pediatric Gastroenterology and Nutrition·Marie O'MearaGiorgina Mieli-Vergani
Nov 2, 2019·Physiological Reviews·Amy C EngevikJames R Goldenring
Sep 1, 2017·Gastroenterology Research and Practice·Pei-Jing CuiJun Yang
Mar 7, 2021·Molecular and Cellular Endocrinology·E VitaliA G Lania
Jan 9, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Damian WildMartyn E Caplin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.